Pfizer Breaks to a New Annual High at $30.52
As seen on the 24/7 Wall St. homepage on October 30, 2026.
Pfizer cleared $30 for the first time in a year, closing at $30.52 and topping its October 22 peak by 0.33%. The $173.9 billion drugmaker was trading near $23 twelve months ago.
Continue ReadingShow less
Pfizer closed at $30.52 on October 30, its first close above $30 in roughly a year and a new annual high.
The stock traded near $23 twelve months ago, so holders have recovered more than $7 a share through a year of pressure.
Sponsored
The move follows months of basing between $23 and $27, the kind of setup that draws momentum-oriented investors once a fresh high prints.
At a market capitalization of $173.9 billion, sustained buying in Pfizer carries weight across the pharmaceutical sector, and holding above $30 in the coming sessions confirms the breakout.
Sources
Mentioned: PFE